Vanda Pharmaceuticals sues U.S. government over drug trade secrets
By Blake Brittain (Reuters) – Vanda Pharmaceuticals Inc has sued the federal government in Washington, D.C., federal court over accusations that the U.S. Food and …
pharmaceuticals
Canada September wholesale trade up 0.1% on pharmaceuticals
Nov 15 (Reuters) – Canadian wholesale trade increased by 0.1% in September from August on the higher sales in the personal and household goods subsector, …
Salix Pharmaceuticals To Share New Data At Digestive Disease Week® 2022
XIFAXAN® (rifaximin), TRULANCE® (plecanatide) and PLENVU® Research Posters Will Be Presented LAVAL, Quebec, May 18, 2022 — Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) …
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) launches Luzsana Biotechnology™ (Luzsana)
Luzsana to co-develop medicines with parent company Hengrui Pharma and commercialize in North America, Europe and Japan Initial pipeline focuses on 11 high-potential programs in …
NRX PHARMACEUTICALS INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of NRx Pharmaceuticals, Inc. – NRXP
NEW ORLEANS, April 22, 2022 — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick …
SALIX PHARMACEUTICALS WILL PRESENT SCIENTIFIC DATA AT THE SOCIETY OF HOSPITAL MEDICINE CONVERGE 2022
Featured Posters Will Include XIFAXAN® (rifaximin) and RELISTOR® (methylnaltrexone bromide) Research BRIDGEWATER, N.J., April 7, 2022 — Salix Pharmaceuticals (“Salix”), the gastroenterology business of Bausch …
Avet Pharmaceuticals Announces Approval and Launch of Propofol Injectable Emulsion, USP
Avet Pharma Announces Approval and Launch of Propofol Injectable Emulsion, USP to address current market shortage Tweet this About Propofol Propofol injectable emulsion is an …
Injectable Drug Delivery Market Size to Reach USD 83.38 Billion in 2030 | Convenience and At-Home Accessibility Afforded by Injectable Pharmaceuticals are Key Factors Driving Industry Demand, Says Emergen Research
VANCOUVER, BC, March 30, 2022 — The global injectable drug delivery market size reached USD 15.13 Billion in 2021 and is expected to register a significantly …
Seton Pharmaceuticals, LLC and Senores Pharmaceuticals, Inc. launch Butalbital, Acetaminophen and Caffeine Capsules USP, 50 mg/325 mg/40 mg in the U.S. market USA – English USA – English
“We are pleased to collaborate with Seton Pharmaceuticals for the commercial launch of Butalbital, Acetaminophen and Caffeine Capsules in the U.S. market” stated Dhananjay Barot, Director, …